Journal of Neurology

, Volume 255, Issue 9, pp 1436–1438

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab

Evidence for disease heterogeneity
  • V. I. Leussink
  • H. C. Lehmann
  • G. Meyer zu Hörste
  • H.-P. Hartung
  • O. Stüve
  • B. C. Kieseier
LETTER TO THE EDITORS

DOI: 10.1007/s00415-008-0956-x

Cite this article as:
Leussink, V.I., Lehmann, H.C., Meyer zu Hörste, G. et al. J Neurol (2008) 255: 1436. doi:10.1007/s00415-008-0956-x

Copyright information

© Springer 2008

Authors and Affiliations

  • V. I. Leussink
    • 1
  • H. C. Lehmann
    • 1
  • G. Meyer zu Hörste
    • 1
  • H.-P. Hartung
    • 1
  • O. Stüve
    • 1
    • 2
    • 3
  • B. C. Kieseier
    • 1
  1. 1.Dept. of NeurologyHeinrich-Heine UniversityDüsseldorfGermany
  2. 2.Neurology SectionVA North Texas Health Care System, Medical ServiceDallasUSA
  3. 3.Dept. of Neurology and Dept. of ImmunologyUniversity of Texas Southwestern Medical, Center at DallasDallasUSA

Personalised recommendations